Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Multimodal approach intriguing for enhancing antiPVR pharmacologicaltherapy
Combination pharmacological therapy offers an appealing strategy forimproving outcomes after retinal detachment surgery, said Mark S. Blumenkranz,MD.The concept of using multimodal regimens stems from understanding themechanisms for the development of proliferative vitreoretinopathy (PVR)and aims to inhibit the pathway at more than one point.
Related Videos
Related Content
